A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance

Authors:

Abstract
No abstract available
Funding Information
  • National Cancer Institute (HHSN261201200031I, P30 CA023074)

This publication has 11 references indexed in Scilit: